Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.

× No keyword cloud information.

8 in total

Review 1. Renal failure and ACE inhibition: how much is too much?

Authors: M-L Gross; M Adamczak; E Ritz
Journal: Z Kardiol Date: 2005-02

2. Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure.

Authors: Inder S Anand; Anita Deswal; Dean J Kereiakes; Das Purkayastha; Dion H Zappe
Journal: Vasc Health Risk Manag Date: 2010-08-09

Review 3. How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?

Authors: Julian Segura; Helle Christiansen; Carlos Campo; Luis M Ruilope
Journal: Curr Hypertens Rep Date: 2003-10 Impact factor: 5.369

Review 4. How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?

Authors: Marc S Weinberg; Nicholas Kaperonis; George L Bakris
Journal: Curr Hypertens Rep Date: 2003-10 Impact factor: 5.369

5. Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors.

Authors: Bernhard Gremmler; Matthias Kunert; Klaus Kisters; Heinrich Schleiting; Ludger J Ulbricht
Journal: Exp Clin Cardiol Date: 2002

6. Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy.

Authors: Zheng He; Yun Sun; Hui Gao; Jun Zhang; Yuhong Lu; Jihua Feng; Hongli Su; Chao Zeng; Anlin Lv; Kang Cheng; Yan Li; Huan Li; Ronghua Luan; Ling Wang; Qiujun Yu
Journal: ESC Heart Fail Date: 2015-07-14

Review 7. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.

Authors: Keiji Kuba; Yumiko Imai; Takayo Ohto-Nakanishi; Josef M Penninger
Journal: Pharmacol Ther Date: 2010-07-03 Impact factor: 12.310

8. Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.

Authors: Joseph L Izzo; Marc S Weinberg; James W Hainer; Joseph Kerkering; Conrad K P Tou
Journal: J Clin Hypertens (Greenwich) Date: 2004-09 Impact factor: 3.738

8 in total